SEK 8.2 billion in proceeds will be freed by Intrum through a planned portfolio sale, funds the company says it will use to cut debt after reporting SEK 60.8 billion of gross debt and 4.4x net leverage at the end of 2023. Intrum said the measures respond to worsening collections, restricted access to capital markets and heavy near-term bond maturities that it says threaten its standalone liquidity profile. The SEK 11.5 billion non-performing loan portfolio sale to Cerberus, agreed in January 2024 at an indicated 2 percent discount to book, will probably close in the second quarter of 2024 and generate the proceeds. Intrum intends to deploy the money to reduce liabilities, a step it warns will lower its expected remaining collections carrying value and cut cash EBITDA by about 20 percent.
Intrum, the pan-European credit management and debt collection group, has set in motion a package of restructuring and asset-sale measures that it says will generate approximately SEK 8.2 billion to pare back debt. The company reported full-year 2023 revenue of SEK 20.0 billion, cash EBITDA of SEK 13.1 billion, and an expected remaining collections carrying value, or ERC, of SEK 76.1 billion.
Why the balance sheet is under pressure
The balance sheet strain has several linked causes. By the end of 2023 Intrum carried SEK 60.8 billion of gross debt and a reported net leverage of 4.4x. Market participants and analysts had regarded those leverage metrics as high for the sector. Management has pointed to worsening collections and limited access to bond markets as immediate constraints on funding options, and it flagged a cluster of upcoming maturities that deepen the pressure on liquidity.
Intrum quantifies the near-term maturities as SEK 7.5 billion falling due in 2024 and SEK 14.0 billion in 2025. Another account emphasised that significant maturities extend into 2025 and 2026. Credit rating downgrades and constrained market access have increased the urgency for liability management, the company said.
The group's historic model combined capital-intensive purchases of portfolios with capital-light servicing contracts. That mix supported growth in better funding conditions, but left the balance sheet exposed when returns weakened and funding became more costly, according to the company. The firm now says it must rebalance the mix to protect its standalone liquidity profile and preserve its ability to serve banking and corporate clients across its markets.
The Cerberus sale and the recapitalisation process
In January 2024 Intrum agreed to sell SEK 11.5 billion of non-performing loan portfolios to Cerberus, at a company-stated 2 percent discount to book. Intrum expects the transaction to produce roughly SEK 8.2 billion of net proceeds when it closes in the second quarter of 2024.
Management has said those proceeds are earmarked for debt reduction.
Intrum warns that using cash to cut liabilities will materially reduce its ERC and its cash EBITDA by about 20 percent. That reflects the sale of a portion of the firm’s investing portfolio, and the company presents the sell-down as a quick liquidity and de-risking step ahead of a broader recapitalisation.
One report describes the current course as a formal recapitalisation process intended to avoid insolvency risk driven by a combination of market downturns, funding stress and rating pressure, and to strengthen Intrum’s capital structure for longer-term stability. The company frames the restructuring as necessary to preserve its ability to continue servicing clients across its markets while addressing its liability profile.
The package of material supplied to researchers and reporters doesn't contain independent confirmation that Intrum will raise $812 million of new equity capital. The documents and summaries focus on the SEK 11.5 billion portfolio sale, the expected SEK 8.2 billion of proceeds, and a broader recapitalisation process rather than specifying an equity injection of that size.
Management has signalled that the debt reduction via the Cerberus transaction is an immediate step, to be followed by further communications about funding options and liability management as the company navigates the 2024-2026 maturity wall. The firm says the goal is to stabilise its capital structure while continuing to serve its bank and corporate clients.
For investors and creditors the trade-off is straightforward. Selling portfolios frees liquidity fast, but it shrinks the asset base that generates future collections and earnings. Intrum has quantified that effect as a roughly 20 percent reduction in ERC and cash EBITDA tied to the portion of the investing portfolio being sold.
The company’s revenue and cash generation at the FY 2023 level provide context for that choice. With SEK 20.0 billion of revenue and SEK 13.1 billion of cash EBITDA, management has chosen a path that sacrifices some future earnings capacity to reduce immediate funding risk and the chance of technical insolvency, according to one account.
That pragmatic framing underlines the limited options available to firms with capital-intensive portfolio holdings when bond markets constrict. Intrum’s approach combines portfolio sales and a structured recapitalisation, rather than relying solely on refinancing in the bond market.
Related Articles
- Africa50 fund nets US$118m, targets US$400m final
- Q3 European profits seen falling as autos and luxury suffer
- China chip fund eyes $45bn DeepSeek lead
The Cerberus portfolio sale will probably close in the second quarter of 2024, when Intrum says it will deploy roughly SEK 8.2 billion of proceeds to cut liabilities as part of a broader recapitalisation aimed at easing heavy maturities through 2024-2026.
This article was created with AI assistance.
